Clear Guide Medical, LLC, founded in Baltimore, United States, is dedicated to revolutionizing the field of medical imaging. The company's core mission is to enhance the precision and efficiency of interventional procedures through advanced imaging technologies. Their flagship product, SCENERGY, integrates with MRI, CT, and ultrasound systems to provide augmented reality-guided procedures such as biopsies and ablations. This technology aims to reduce the need for intermediate imaging and improve the success rates of venous access and other critical medical interventions.

Notable figures associated with Clear Guide Medical include key investors and advisors from the medical technology sector, though specific names are not publicly highlighted. The company has achieved significant milestones in improving procedural accuracy and efficiency, as evidenced by clinical studies demonstrating reduced failure rates with their technology. Clear Guide Medical's impact is marked by its contribution to more precise targeting in medical procedures, ultimately enhancing patient outcomes and operational efficiency in healthcare settings.